Intractable hemorrhagic cystitis after hematopoietic stem cell tranplantation--is there a role for early urinary diversion in children?

PURPOSE: Severe hemorrhagic cystitis is a major complication in the pediatric population undergoing hematopoietic stem cell transplantation. Percutaneous nephrostomy tube drainage as a treatment for severe hemorrhagic cystitis has rarely been investigated. We examined children undergoing hematopoietic stem cell transplantation for risk factors associated with severe hemorrhagic cystitis, as well as our experience with percutaneous nephrostomy tube placement as an adjunctive management strategy. MATERIALS AND METHODS: Using prospectively collected data from the Blood and Marrow Transplant Database at the University of Minnesota, we reviewed 40 pediatric patients with severe hemorrhagic cystitis from 1996 to 2010. Specific treatment for each patient was administered at the discretion of the attending physician and generally included bladder irrigation before bladder fulguration or percutaneous nephrostomy tube placement. A percutaneous nephrostomy tube was placed in 11 patients due to the intractable nature of the hemorrhagic cystitis. RESULTS: Of the 11 patients who underwent percutaneous nephrostomy tube drainage 5 (45%) had improvement of the hemorrhagic cystitis within 30 days and the same number had long-term resolution. Among the patients with long-term resolution hemorrhagic cystitis resolved an average of 12.4 days after percutaneous nephrostomy tube placement, and the tubes were removed an average of 8.8 weeks after placement. Through September 2011 mortality among patients with percutaneous nephrostomy tubes was 55% (6 of 11 patients), which was identical to the overall mortality in the severe hemorrhagic cystitis group (22 of 40). No death could be directly attributed to hemorrhagic cystitis or percutaneous nephrostomy tube placement. CONCLUSIONS: Placement of percutaneous nephrostomy tubes for treatment of severe hemorrhagic cystitis results in long-term improvement in intractable hemorrhagic cystitis, and is a safe and viable option for the majority of patients.

Postradiotherapy intratesticular leiomyosarcoma.

We report what we believe to be the first case of high-grade, radiation-induced, intratesticular leiomyosarcoma in a 30-year-old man who had had testicular relapse of acute lymphoblastic leukemia at age 12 years that was treated with standard testicular field radiation (2400 cGy) and chemotherapy. Radiation-induced tumors of this type are rare, have a median latency of 10 years, and are usually dose dependent (around 5000 cGy). Testicular leiomyosarcoma, especially high grade, remains to be fully characterized. After radical orchiectomy, patients should be followed up with serial germ cell tumor markers and imaging to monitor for metastatic spread. The use of retroperitoneal lymph node dissection and chemotherapy remains controversial but is probably not indicated.

Percutaneous renal stone extraction: in vitro study of retrieval devices.

PURPOSE: Traditionally, percutaneous stone extraction has relied on the use of 2-prong and 3-prong graspers, which are prone to causing trauma to the urothelium. We evaluate the efficiency of stone removal with a novel tipless stone basket designed specifically for percutaneous procedures. MATERIALS AND METHODS: A 3, 5 and 8 mm human calculus were placed in the calix of a percutaneous renal model. A 26Fr Storz nephroscope (27093B, Storz Medical AG, Kreuzlingen, Switzerland) was inserted through a 30Fr Amplatz sheath into the model with camera input from a Storz telecam SL-NTSC feeding to a 20-inch Sony Triniton monitor (Sony Corp of America, New York, New York). Operators were randomized to start stone extraction with a Storz 3-prong grasper (27090RB) or a Cook 12Fr Perc-NCircle (38 cm) (Cook Urological, Inc., Indianapolis, Indiana). Subsequent testing alternated between the 2 devices until 10 extraction attempts were conducted with each device. Time to extraction of all 3 calculi and number of inadvertent withdrawals of the sheath were recorded. Three experienced operators tested each device. RESULTS: Stone extraction times were shorter with the Cook Perc-NCircle than the 3-prong grasper for all operators. Mean time for stone extraction was 25.3 +/- 11.2 seconds for the Perc-NCircle compared to 35.1 +/- 18.5 seconds for the 3-prong grasper (p = 0.016). Loss of access by inadvertent removal of the Amplatz sheath occurred in 53% of the attempts with the 3-prong grasper compared to 7% of attempts with the Perc-NCircle. CONCLUSIONS: The Cook Perc-NCircle facilitates a more expeditious approach to percutaneous stone removal with less risk of sheath withdrawal.